Methyl salicylate 2-O-β-D-lactoside as an anti-inflammatory agent
Author Information
Author(s): Lan Xi, Liu Rui, Sun Lan, Zhang Tiantai, Du Guanhua
Primary Institution: Beijing Key Laboratory of Drug Target and Screening Research, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College
Hypothesis
The study aimed to evaluate the anti-inflammatory effects of DL0309 on microglia and astrocytes.
Conclusion
DL0309 may be effective in treating neuroinflammatory disorders, including Alzheimer's disease, by suppressing pro-inflammatory cytokines and regulating the NF-κB signaling pathway.
Supporting Evidence
- DL0309 significantly inhibits the release of pro-inflammatory cytokines IL-6, IL-1β, and TNF-α.
- At a concentration of 10 μM, DL0309 inhibits LPS-induced activation of NF-κB in glial cells.
- DL0309 acts as a non-selective COX inhibitor in glial cells.
Takeaway
A new compound called DL0309 can help reduce inflammation in brain cells, which might be useful for treating diseases like Alzheimer's.
Methodology
The study involved incubating microglia and astrocytes with DL0309 and measuring the levels of pro-inflammatory cytokines and proteins after LPS stimulation.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website